Northern Trust Company of Connecticut’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
$18.8M Sell
282,161
-27,125
-9% -$1.76M 0.12% 236
2013
Q3
$19.4M Buy
309,286
+39,928
+15% +$2.57M 0.13% 220
2013
Q2
$16.8M Buy
+269,358
New +$17.1M 0.11% 249

Other funds holding GSK

Northern Trust Company of Connecticut's GSK Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its GSK (GSK) stake by 8.8% in Q4 2013, selling an estimated $1.76M and leaving 282,161 shares worth $18.8M. The position accounts for 0.12% of the portfolio, ranked #236.

Northern Trust Company of Connecticut first reported a position in GSK in Q2 2013 and has held it in 3 quarters since. The position peaked at $19.4M in Q3 2013. 682 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

  • Northern Trust Company of Connecticut held 282,161 shares of GSK worth $18.8M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 27,125 GSK shares in Q4 2013, an estimated $1.76M.
  • GSK made up 0.12% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #236 holding.
  • Northern Trust Company of Connecticut first reported a position in GSK in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's GSK position peaked at $19.4M in Q3 2013.
  • 682 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.